Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, and description adds: it pulls latest 10-K data handling fiscal year offsets, sorts results by primary metric, and for drugs summarizes FAERS, FDA approvals, trials. No contradictions; the description enriches the behavioral context beyond the annotation safety profile.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

A single dense paragraph that front-loads examples and key advice, then methodically covers types and data sources. Every sentence adds value—no redundancy. The structure is easy to scan and understand.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description adequately explains output format: 'paired data + pipeworx:// citation URIs per entity' and mentions sorting. It covers all input variations and provides enough detail for an agent to invoke the tool correctly and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds critical context: explains type='company' means SEC financials (revenue, net income, cash, debt) and type='drug' means regulatory/trial counts, and clarifies values array expects tickers/CIKs vs drug names with explicit bounds (2–5 items). This goes well beyond the schema's minimal descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description starts with concrete query examples ('Compare X and Y', 'X vs Y', etc.) and precisely states the tool performs side-by-side comparison of 2–5 companies or drugs in one parallel call. It clearly distinguishes from sequential lookups and specifies the data pulled per type (SEC financials for companies, FAERS/FDA/trials for drugs).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly advises 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', provides example queries, and notes it replaces 8–15 sequential lookups. This gives clear when-to-use guidance and implicitly sets boundaries (use when comparing, not for single entity profiles).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

Most tools have distinct purposes and the descriptions are unusually thorough, but ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, and several discovery/prediction-market tools (polymarket_edges vs polymarket_arbitrage, discover_tools vs suggest_questions) occupy overlapping territory. An agent could reasonably route to the wrong variant despite the documentation.

Naming Consistency4/5

The dominant convention is lowercase snake_case with a leading verb (ask_pipeworx, list_subscriptions, validate_claim, resolve_entity), which makes the set predictable. A few noun-first outliers like pipeworx_trending, recent_alerts, and polymarket_edge_tracker are minor deviations rather than a broken pattern.

Tool Count2/5

34 tools is well above the coherence sweet spot for an MCP server, and much of that count is made up of meta-wrappers and convenience variants around the same Pipeworx router. The broad scope explains some of the count, but the surface still feels heavy for a single named server.

Completeness3/5

The Pipeworx side is very complete: lookups, grounded verification, research, entity profiles, comparisons, prediction-market fill checks, subscriptions, and memory all have lifecycle coverage. However, the server is named Obis and only find_occurrences, get_statistics, and get_taxon serve that domain, leaving obvious marine-biodiversity operations like occurrence detail, dataset listing, and download paths missing.